Tumor response to induction chemoradiation: Influence on survival after esophagectomy

European Journal of Cardio-thoracic Surgery

Volumn 24, Issue 4, 2003, Pages 631-637

  Donington, Jessica S ^a   Miller, Daniel L ^b   Allen, Mark S ^a   Deschamps, Claude ^a   Nichols III, Francis C ^a   Pairolero, Peter C ^a  

^a MAYO CLINIC   (United States)

^b EMORY CLINIC   (United States)

Author keywords

Esophageal cancer; Esophagectomy; Neoadjuvant chemoradiation; Pathology

Indexed keywords

CISPLATIN; FLUOROURACIL; ONDANSETRON;

ADENOCARCINOMA; ADULT; AGED; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CONFERENCE PAPER; CONTROLLED STUDY; DRUG RESPONSE; ESOPHAGUS CARCINOMA; ESOPHAGUS RESECTION; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MULTIMODALITY CANCER THERAPY; PREDICTION; PREOPERATIVE RADIOTHERAPY; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RADIATION RESPONSE; SURGICAL MORTALITY; TREATMENT OUTCOME;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; FOLLOW-UP STUDIES; HOSPITAL MORTALITY; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0141515468     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1010-7940(03)00397-X     Document Type: Conference Paper

References (25)

1. Lehnert T. Multimodality therapy for squamous carcinoma of the oesophagus. Br J Surg. 86:1999;727-739.
2. Roth R.A., Putnam J.B., Rich T.A. Cancer of the esophagus. DeVita V.T. Jr, Hellman S., Rosenberg S.A. Cancer principles and practice of oncology. 1996;980-1054 Lippincott, Philadelphia, PA.
3. Franklin R., Steiger Z., Vaishampayan G., Asfaw I., Rosenberg J., Loh J. Combined modality therapy for esophageal squamous cell carcinoma. Cancer. 51:1983;1062-1071.
4. Leichman L., Steiger Z., Seydel H.G., Dindogru A., Kinzie J., Toben J., Mackenzie G., Shell J. Preoperative chemotherapy and radiation therapy for patients with cancer of the esophagus: a potentially curative approach. J Clin Oncol. 2:1984;75-79.
5. Seydel H.G., Leichman L., Byhardt R., Cooper J., Herskovic A., Libnock J., Pazdor R., Speyer J., Tschan J. Preoperative radiation and chemotherapy for localized squamous cell carcinoma of the esophagus: A RTOG Study. Int J Radiat Oncol Biol Phys. 14:1988;33-35.
6. Poplin E., Flemming T., Leichman L., Seydel G., Steiger Z., Taylor S., Vance R., Stuckey W., Rivkin S.E. Combined therapies for squamous cell carcinomas of the esophagus, a Southwest Oncology Group (SWOG 8037). J Clin Oncol. 5:1987;622-628.
7. Forastiere A.A., Orringer M.B., Perez-Tamayo C., Urba S.G., Zahurak M. Preoperative chemoradiation followed by transhiatal esophagectomy for carcinoma of the esophagus: final report. J Clin Oncol. 11:1993;1118-1123.
8. Leprise E., Etienne P.L., Meunier B., Maddern G., Hassen M.B., Gedouin D., Boutin D., Campion J.P., Launois B. A randomized study of chemotherapy, radiation therapy, and surgery versus surgery alone for localized squamous cell carcinoma of the esophagus. Cancer. 73:1994;1779-1784.
9. Bates B.A., Detterbeck F., Bernard S., Qaqish B.F., Tepper J.E. Concurrent radiation therapy and chemotherapy followed by esophagectomy for localized esophageal carcinoma. J Clin Oncol. 14:1996;156-163.
10. Walsh T.N., Noonan N., Hollywood D., Kelly A., Keeling N., Hennessy T.P.J. A comparison of multimodality therapy and surgery for esophageal adenocarcinoma. N Engl J Med. 335:1999;462-467.
11. Adelstein D.J., Rice T.W., Becker M., Larto M.A., Kirby T.J., Koka A., Tefft M., Zuccaro G. Use of concurrent chemotherapy, accelerated fractional radiation, and surgery for patients with esophageal carcinoma. Cancer. 80:1997;1011-1020.
12. Urba S.G., Orringer M.B., Turrisi A., Iannettoni M., Forastiere A.A., Strawderman M. Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol. 19:2001;305-313.
13. Manual for staging of cancer. 3rd ed:1988;Lippincott, Philadelphia, PA.
14. Kaplan E., Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc. 53:1958;457-481.
15. Peto R., Peto J. Asymptotically efficient rank invariant procedures (with discussion). J R Stat Soc A. 135:1972;185-207.
16. Cox D.R. Regression models and life-tasks. J R Stat Soc B. 34:1972;187-220.
17. Orringer M.B., Marshall B., Iannettoni M.D. Transhiatal esophagectomy: clinical experience and refinements. Ann Surg. 230:1999;392-403.
18. Coia L.R., Engstrom P.F., Paul A.R., Stafford P.M., Haines G.E. Long-term results of infusional 5-FU, mitomycin-C, and radiation as primary management of esophageal cancer. Int J Radiat Oncol Biol Phys. 20:1991;29-36.
19. Liechman L., Herskovic A., Liechman C.G., Latin P.B., Steiger Z., Tapazoglou E., Rosenberg J., Arbulu A., Asfaw I., Kinzie J. Nonoperative management for squamous-cell carcinoma of the esophagus. J Clin Oncol. 5:1987;365-370.
20. Herskovic A., Martz K., Al-Sarraf A., Liechman L., Brendle J., Vaitikevicius V., Cooper J. Combined chemotherapy and radiotherapy compared to radiotherapy alone in patients with cancer of the esophagus. N Engl J Med. 326:1992;1593-1598.
21. Al-Sarraf M., Martz K., Herskovic A., Liechman L., Brindle J., Vaitikevicius V., Cooper J. Progress report of combined preoperative chemoradiotherapy alone in patients with esophageal cancer: an intergroup study. J Clin Oncol. 15:1997;277-284.
22. Urba S., Orringer M., Perez-Tamayo C., Bromberg J., Forastiere A.A. Concurrent preoperative chemotherapy and radiation therapy in localized esophageal adenocarcinoma. Cancer. 69:1992;285-291.
23. Jones D.R., Detterbeck F.C., Egan T.M., Parker L.A., Bernard S.A., Tepper J.E. Induction chemotherapy followed by esophagectomy in patients with carcinoma of the esophagus. Ann Thorac Surg. 64:1997;185-192.
24. Zuccaro G., Rice T.W., Golgblum J., Medendorp S.V., Becker M., Pimenter R., Gitlin L., Adelstein D.J. Endoscopic ultrasound can not determine suitability for esophagectomy after aggressive chemoradiotherapy for esophageal cancer. Am J Gastroenterol. 94:1999;906-912.
25. Kim H.J., Choi E.K., Kim S.B., Park S.I., Kim D.K., Song H.Y., Jung H.Y., Min Y.I. Preoperative hyperfractionated radiotherapy with concurrent radiotherapy in resectable esophageal cancer. Int J Radiat Oncol Biol Phys. 50:2001;1-12.